InvestSMART

Pacific Edge Limited (ASX: PEB) - Announcements

Current share price for PEB : $0.200 0.015 (6.98%)+

ASX company news and announcements for Pacific Edge Limited (PEB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pacific Edge Limited (PEB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pacific Edge Limited (PEB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pacific Edge Limited (PEB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$248 PEB Completes Oversubscribed NZ$36.1m Capital Raise 3 Jun 2026 7:30AM $0.225 $0.200 fallen by 11.11%
$248 Change in substantial holding 27 May 2026 3:17PM $0.215 $0.200 fallen by 6.98%
$248 Retail Offer Reminder 25 May 2026 8:26AM $0.210 $0.200 fallen by 4.76%
$248 Advancing Medicare Coverage Goals Cost Contained 25 May 2026 7:31AM $0.210 $0.200 fallen by 4.76%
$248 NZX D&O Disclosures - Multiple 21 May 2026 12:45PM $0.225 $0.200 fallen by 11.11%
$248 SPH Notice - ANZ New Zealand Investments Limited 19 May 2026 7:30AM $0.235 $0.200 fallen by 14.89%
$248 NZX - Capital Change Notice 15 May 2026 2:12PM $0.220 $0.200 fallen by 9.09%
$248 Application for quotation of securities - PEB 15 May 2026 1:58PM $0.205 $0.200 fallen by 2.44%
$248 Draft LCD Proposes Medicare Coverage for Triage and Triage 15 May 2026 7:30AM $0.145 $0.200 risen by 37.93%
$248 Pacific Edge Opens NZ$6 Million Retail Offer 14 May 2026 7:31AM $0.145 $0.200 risen by 37.93%
$248 Pacific Edge Placement Increased to NZ$25.4 Million 13 May 2026 8:27AM $0.145 $0.200 risen by 37.93%
$248 Pacific Edge FY26 Result to be Announced 25 May 2026 12 May 2026 8:23AM $0.145 $0.200 risen by 37.93%
$248 Trading Halt 11 May 2026 8:49AM $0.145 $0.200 risen by 37.93%
$248 Proposed issue of securities - PEB 11 May 2026 7:30AM $0.145 $0.200 risen by 37.93%
$248 Pacific Edge Launches NZ$24 Million Capital Raise 11 May 2026 7:30AM $0.145 $0.200 risen by 37.93%
$248 Q4 26 Test Volumes Rise with Medicare Policy Momentum 10 Apr 2026 7:32AM $0.145 $0.200 risen by 37.93%
$248 Application for quotation of securities - PEB 25 Mar 2026 3:30PM $0.155 $0.200 risen by 29.03%
$248 Notification of cessation of securities - PEB 25 Mar 2026 3:25PM $0.155 $0.200 risen by 29.03%
$248 First Triage Plus Tests Ordered from Townsville 5 Mar 2026 7:30AM $0.165 $0.200 risen by 21.21%
$248 Change in substantial holding 4 Mar 2026 11:52AM $0.178 $0.200 risen by 12.68%
$248 Leading Singapore Hospital Now Ordering Cxbladder 3 Mar 2026 7:30AM $0.170 $0.200 risen by 17.65%
$248 Panel Expresses Support for Urine-Based Biomarkers 23 Feb 2026 9:21AM $0.200 $0.200 fallen by 0%
$248 Trading Halt 20 Feb 2026 9:25AM $0.200 $0.200 fallen by 0%
$248 Change in substantial holding 13 Feb 2026 2:11PM $0.195 $0.200 risen by 2.56%
$248 Medicare Contractor Novitas Schedules Expert Panel 9 Feb 2026 9:01AM $0.165 $0.200 risen by 21.21%

26 - 50 of 265 results

Page 2 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.